{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:22:19Z","timestamp":1783642939810,"version":"3.55.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-72647-7","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:48:47Z","timestamp":1777999727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ER\u03b1 blockade in dendritic cells enhances antigen cross-presentation and induces antitumor CD8+ T cell immunity"],"prefix":"10.1038","volume":"17","author":[{"given":"Yaxin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongfei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0409-1121","authenticated-orcid":false,"given":"Yumei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0293-585X","authenticated-orcid":false,"given":"Shuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9448-7718","authenticated-orcid":false,"given":"Lianjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4838-3552","authenticated-orcid":false,"given":"Chunmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9677-7647","authenticated-orcid":false,"given":"Xuetao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"72647_CR1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41568-025-00820-z","volume":"25","author":"N Zaidi","year":"2025","unstructured":"Zaidi, N., Jaffee, E. M. & Yarchoan, M. Recent advances in therapeutic cancer vaccines. Nat. Rev. Cancer 25, 517\u2013533 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"72647_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4049\/jimmunol.1701024","volume":"200","author":"PM Santos","year":"2018","unstructured":"Santos, P. M. & Butterfield, L. H. Dendritic cell-based cancer vaccines. J. Immunol. 200, 443\u2013449 (2018).","journal-title":"J. Immunol."},{"key":"72647_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","volume":"20","author":"SK Wculek","year":"2020","unstructured":"Wculek, S. K. et al. Dendritic cells in cancer immunology and immunotherapy. Nat. Rev. Immunol. 20, 7\u201324 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"72647_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114003","volume":"43","author":"L Peng","year":"2024","unstructured":"Peng, L. et al. Hippo-signaling-controlled MHC class I antigen processing and presentation pathway potentiates antitumor immunity. Cell Rep. 43, 114003 (2024).","journal-title":"Cell Rep."},{"key":"72647_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adf4919","volume":"8","author":"L Wu","year":"2023","unstructured":"Wu, L. et al. Noncanonical MAVS signaling restrains dendritic cell-driven antitumor immunity by inhibiting IL-12. Sci. Immunol. 8, eadf4919 (2023).","journal-title":"Sci. Immunol."},{"key":"72647_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s44466-025-00007-z","volume":"1","author":"A Bates","year":"2025","unstructured":"Bates, A., Fletcher, N. E., Gao, F., Pinho, M. P. & Dong, T. Leveraging T cells for cancer immunotherapy. Immun. Inflamm. 1, 9 (2025).","journal-title":"Immun. Inflamm."},{"key":"72647_CR7","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1126\/science.1164206","volume":"322","author":"K Hildner","year":"2008","unstructured":"Hildner, K. et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 322, 1097\u20131100 (2008).","journal-title":"Science"},{"key":"72647_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s44466-025-00019-9","volume":"2","author":"H Yanai","year":"2026","unstructured":"Yanai, H. & Taniguchi, T. The IRF transcription factor family in type I interferon-mediated antiviral immunity and associated diseases. Immun. Inflamm. 2, 1 (2026).","journal-title":"Immun. Inflamm."},{"key":"72647_CR9","doi-asserted-by":"crossref","unstructured":"Nakkala J. R., Li Y., Akter L., Kang X. & Chen X. Differential regulation of DC function, adaptive immunity, and MyD88 dependence by two squalene emulsion-based vaccine adjuvants. Vaccines 12, 531 (2024).","DOI":"10.3390\/vaccines12050531"},{"key":"72647_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/ni.3535","volume":"17","author":"Y Ding","year":"2016","unstructured":"Ding, Y. et al. The lectin Siglec-G inhibits dendritic cell cross-presentation by impairing MHC class I-peptide complex formation. Nat. Immunol. 17, 1167\u20131175 (2016).","journal-title":"Nat. Immunol."},{"key":"72647_CR11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1126\/science.1251456","volume":"344","author":"P Wang","year":"2014","unstructured":"Wang, P. et al. The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation. Science 344, 310\u2013313 (2014).","journal-title":"Science"},{"key":"72647_CR12","first-page":"822s","volume":"7","author":"W Zhang","year":"2001","unstructured":"Zhang, W. et al. Genetic approach to insight into the immunobiology of human dendritic cells and identification of CD84-H1, a novel CD84 homologue. Clin. Cancer Res. 7, 822s\u2013829s (2001).","journal-title":"Clin. Cancer Res."},{"key":"72647_CR13","doi-asserted-by":"publisher","first-page":"6238","DOI":"10.4049\/jimmunol.161.11.6238","volume":"161","author":"X Cao","year":"1998","unstructured":"Cao, X. et al. Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity. J. Immunol. 161, 6238\u20136244 (1998).","journal-title":"J. Immunol."},{"key":"72647_CR14","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41586-023-06057-w","volume":"618","author":"JJ Lee","year":"2023","unstructured":"Lee, J. J. et al. ER\u03b1-associated translocations underlie oncogene amplifications in breast cancer. Nature 618, 1024\u20131032 (2023).","journal-title":"Nature"},{"key":"72647_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41568-023-00604-3","volume":"23","author":"M Will","year":"2023","unstructured":"Will, M., Liang, J., Metcalfe, C. & Chandarlapaty, S. Therapeutic resistance to anti-oestrogen therapy in breast cancer. Nat. Rev. Cancer 23, 673\u2013685 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"72647_CR16","doi-asserted-by":"publisher","first-page":"mjad047","DOI":"10.1093\/jmcb\/mjad047","volume":"15","author":"LB Cao","year":"2024","unstructured":"Cao, L. B. et al. Estrogen receptor \u03b1-mediated signaling inhibits type I interferon response to promote breast carcinogenesis. J. Mol. Cell Biol. 15, mjad047 (2024).","journal-title":"J. Mol. Cell Biol."},{"key":"72647_CR17","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1016\/j.cell.2021.08.036","volume":"184","author":"Y Xu","year":"2021","unstructured":"Xu, Y. et al. ER\u03b1 is an RNA-binding protein sustaining tumor cell survival and drug resistance. Cell 184, 5215\u20135229 (2021).","journal-title":"Cell"},{"key":"72647_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12016-010-8203-5","volume":"40","author":"M Cunningham","year":"2011","unstructured":"Cunningham, M. & Gilkeson, G. Estrogen receptors in immunity and autoimmunity. Clin. Rev. Allergy Immunol. 40, 66\u201373 (2011).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"72647_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02003-w","volume":"21","author":"T Wang","year":"2021","unstructured":"Wang, T. et al. Estrogen\/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment. Cancer Cell Int. 21, 295 (2021).","journal-title":"Cancer Cell Int."},{"key":"72647_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3389\/fimmu.2017.00108","volume":"8","author":"S Laffont","year":"2017","unstructured":"Laffont, S., Seillet, C. & Gu\u00e9ry, J. C. Estrogen receptor-dependent regulation of dendritic cell development and function. Front Immunol. 8, 108 (2017).","journal-title":"Front Immunol."},{"key":"72647_CR21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.yhbeh.2012.04.011","volume":"62","author":"S Kovats","year":"2012","unstructured":"Kovats, S. Estrogen receptors regulate an inflammatory pathway of dendritic cell differentiation: mechanisms and implications for immunity. Horm. Behav. 62, 254\u2013262 (2012).","journal-title":"Horm. Behav."},{"key":"72647_CR22","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/imm.13541","volume":"167","author":"ML Lennard Richard","year":"2022","unstructured":"Lennard Richard, M. L. et al. Conditional knockout of oestrogen receptor alpha in CD11c(+) cells impacts female survival and inflammatory cytokine profile in murine lupus. Immunology 167, 354\u2013367 (2022).","journal-title":"Immunology"},{"key":"72647_CR23","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202154228","volume":"24","author":"YM Khaw","year":"2023","unstructured":"Khaw, Y. M. et al. Estrogen receptor alpha signaling in dendritic cells modulates autoimmune disease phenotype in mice. EMBO Rep. 24, e54228 (2023).","journal-title":"EMBO Rep."},{"key":"72647_CR24","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3389\/fimmu.2012.00331","volume":"3","author":"SA Fuertes Marraco","year":"2012","unstructured":"Fuertes Marraco, S. A. et al. Novel murine dendritic cell lines: a powerful auxiliary tool for dendritic cell research. Front Immunol. 3, 331 (2012).","journal-title":"Front Immunol."},{"key":"72647_CR25","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","volume":"566","author":"D Han","year":"2019","unstructured":"Han, D. et al. Anti-tumour immunity controlled through mRNA m(6)A methylation and YTHDF1 in dendritic cells. Nature 566, 270\u2013274 (2019).","journal-title":"Nature"},{"key":"72647_CR26","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.cell.2015.05.025","volume":"161","author":"JR Cubillos-Ruiz","year":"2015","unstructured":"Cubillos-Ruiz, J. R. et al. ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell 161, 1527\u20131538 (2015).","journal-title":"Cell"},{"key":"72647_CR27","doi-asserted-by":"publisher","first-page":"6020","DOI":"10.1073\/pnas.89.13.6020","volume":"89","author":"J Karttunen","year":"1992","unstructured":"Karttunen, J., Sanderson, S. & Shastri, N. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc. Natl. Acad. Sci. USA 89, 6020\u20136024 (1992).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72647_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-020-00939-6","volume":"13","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Dendritic cell biology and its role in tumor immunotherapy. J. Hematol. Oncol. 13, 107 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"72647_CR29","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1073\/pnas.0712394105","volume":"105","author":"ML Lin","year":"2008","unstructured":"Lin, M. L. et al. Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset. Proc. Natl. Acad. Sci. USA 105, 3029\u20133034 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72647_CR30","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1126\/science.adg8802","volume":"380","author":"P Rodr\u00edguez-Silvestre","year":"2023","unstructured":"Rodr\u00edguez-Silvestre, P. et al. Perforin-2 is a pore-forming effector of endocytic escape in cross-presenting dendritic cells. Science 380, 1258\u20131265 (2023).","journal-title":"Science"},{"key":"72647_CR31","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.cell.2011.11.021","volume":"147","author":"I Cebrian","year":"2011","unstructured":"Cebrian, I. et al. Sec22b regulates phagosomal maturation and antigen crosspresentation by dendritic cells. Cell 147, 1355\u20131368 (2011).","journal-title":"Cell"},{"key":"72647_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111205","volume":"40","author":"M Gros","year":"2022","unstructured":"Gros, M. et al. Endocytic membrane repair by ESCRT-III controls antigen export to the cytosol during antigen cross-presentation. Cell Rep. 40, 111205 (2022).","journal-title":"Cell Rep."},{"key":"72647_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.devcel.2019.10.025","volume":"52","author":"J Jia","year":"2020","unstructured":"Jia, J. et al. Galectin-3 coordinates a cellular system for lysosomal repair and removal. Dev. Cell 52, 69\u201387 (2020).","journal-title":"Dev. Cell"},{"key":"72647_CR34","doi-asserted-by":"publisher","first-page":"eaar5078","DOI":"10.1126\/science.aar5078","volume":"360","author":"ML Skowyra","year":"2018","unstructured":"Skowyra, M. L., Schlesinger, P. H., Naismith, T. V. & Hanson, P. I. Triggered recruitment of ESCRT machinery promotes endolysosomal repair. Science 360, eaar5078 (2018).","journal-title":"Science"},{"key":"72647_CR35","doi-asserted-by":"publisher","first-page":"D596","DOI":"10.1093\/nar\/gkab1020","volume":"50","author":"M Li","year":"2022","unstructured":"Li, M. et al. DISCO: a database of deeply integrated human single-cell omics data. Nucleic Acids Res. 50, D596\u2013d602 (2022).","journal-title":"Nucleic Acids Res"},{"key":"72647_CR36","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1016\/S1470-2045(13)70585-0","volume":"15","author":"S Anguille","year":"2014","unstructured":"Anguille, S., Smits, E. L., Lion, E., van Tendeloo, V. F. & Berneman, Z. N. Clinical use of dendritic cells for cancer therapy. Lancet Oncol. 15, e257\u2013e267 (2014).","journal-title":"Lancet Oncol."},{"key":"72647_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12950-025-00436-y","volume":"1","author":"L Zhao","year":"2025","unstructured":"Zhao, L. et al. A multicenter retrospective study of HDAC inhibitor-based regimen for relapsed\/refractory non-hodgkin lymphoma patients post CAR-T therapy. Immunity &. Inflammation 1, 8 (2025).","journal-title":"Inflammation"},{"key":"72647_CR38","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.1158\/0008-5472.CAN-04-3912","volume":"65","author":"Y Wu","year":"2005","unstructured":"Wu, Y. et al. Hsp70-like protein 1 fusion protein enhances induction of carcinoembryonic antigen-specific CD8+ CTL response by dendritic cell vaccine. Cancer Res. 65, 4947\u20134954 (2005).","journal-title":"Cancer Res."},{"key":"72647_CR39","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1182\/blood-2003-08-2828","volume":"103","author":"T Wan","year":"2004","unstructured":"Wan, T. et al. Novel heat shock protein Hsp70L1 activates dendritic cells and acts as a Th1 polarizing adjuvant. Blood 103, 1747\u20131754 (2004).","journal-title":"Blood"},{"key":"72647_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/cmi.2016.33","volume":"15","author":"S Liu","year":"2018","unstructured":"Liu, S. et al. HSP70L1-mediated intracellular priming of dendritic cell vaccination induces more potent CTL response against cancer. Cell Mol. Immunol. 15, 135\u2013145 (2018).","journal-title":"Cell Mol. Immunol."},{"key":"72647_CR41","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1158\/2326-6066.CIR-14-0177","volume":"3","author":"H Zhang","year":"2015","unstructured":"Zhang, H. et al. Cell-free tumor microparticle vaccines stimulate dendritic cells via cGAS\/STING signaling. Cancer Immunol. Res. 3, 196\u2013205 (2015).","journal-title":"Cancer Immunol. Res"},{"key":"72647_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adj3945","volume":"9","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. STING licensing of type I dendritic cells potentiates antitumor immunity. Sci. Immunol. 9, eadj3945 (2024).","journal-title":"Sci. Immunol."},{"key":"72647_CR43","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/1878-0261.13083","volume":"16","author":"D H\u00fchn","year":"2022","unstructured":"H\u00fchn, D. et al. Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells. Mol. Oncol. 16, 148\u2013165 (2022).","journal-title":"Mol. Oncol."},{"key":"72647_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1034990","volume":"9","author":"A Khan","year":"2022","unstructured":"Khan, A., Ali, L. & Wei, D. Q. Editorial: Breast cancer resistance, biomarkers and therapeutics development in the era of artificial intelligence. Front Mol. Biosci. 9, 1034990 (2022).","journal-title":"Front Mol. Biosci."},{"key":"72647_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42480-3","volume":"14","author":"D Calzada-Fraile","year":"2023","unstructured":"Calzada-Fraile, D. et al. Immune synapse formation promotes lipid peroxidation and MHC-I upregulation in licensed dendritic cells for efficient priming of CD8(+) T cells. Nat. Commun. 14, 6772 (2023).","journal-title":"Nat. Commun."},{"key":"72647_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35615-5","volume":"14","author":"X Lei","year":"2023","unstructured":"Lei, X. et al. CD4(+) helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment. Nat. Commun. 14, 217 (2023).","journal-title":"Nat. Commun."},{"key":"72647_CR47","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202216523","volume":"14","author":"A Martinez-Usatorre","year":"2022","unstructured":"Martinez-Usatorre, A. & De Palma, M. Dendritic cell cross-dressing and tumor immunity. EMBO Mol. Med 14, e16523 (2022).","journal-title":"EMBO Mol. Med"},{"key":"72647_CR48","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41590-020-00824-x","volume":"22","author":"J Canton","year":"2021","unstructured":"Canton, J. et al. The receptor DNGR-1 signals for phagosomal rupture to promote cross-presentation of dead-cell-associated antigens. Nat. Immunol. 22, 140\u2013153 (2021).","journal-title":"Nat. Immunol."},{"key":"72647_CR49","doi-asserted-by":"publisher","first-page":"e0238484","DOI":"10.1371\/journal.pone.0238484","volume":"15","author":"SC Nalle","year":"2020","unstructured":"Nalle, S. C. et al. Aquaporin-3 regulates endosome-to-cytosol transfer via lipid peroxidation for cross presentation. PLoS One 15, e0238484 (2020).","journal-title":"PLoS One"},{"key":"72647_CR50","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nprot.2017.016","volume":"12","author":"J Joung","year":"2017","unstructured":"Joung, J. et al. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat. Protoc. 12, 828\u2013863 (2017).","journal-title":"Nat. Protoc."},{"key":"72647_CR51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-1-0716-2938-3_6","volume":"2618","author":"Y Gerber-Ferder","year":"2023","unstructured":"Gerber-Ferder, Y., Bourdely, P., Vetillard, M., Guermonprez, P. & Helft, J. In vitro generation of murine bone marrow-derived dendritic cells. Methods Mol. Biol. 2618, 83\u201392 (2023).","journal-title":"Methods Mol. Biol."},{"key":"72647_CR52","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/cmi.2011.21","volume":"8","author":"Q Fu","year":"2011","unstructured":"Fu, Q. et al. Efficient induction of a Her2-specific anti-tumor response by dendritic cells pulsed with a Hsp70L1-Her2(341-456) fusion protein. Cell Mol. Immunol. 8, 424\u2013432 (2011).","journal-title":"Cell Mol. Immunol."},{"key":"72647_CR53","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/14653240410006040","volume":"6","author":"G Ramadan","year":"2004","unstructured":"Ramadan, G., Konings, S., Kurup, V. P. & Keever-Taylor, C. A. Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC. Cytotherapy 6, 223\u2013234 (2004).","journal-title":"Cytotherapy"},{"key":"72647_CR54","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41421-022-00501-3","volume":"8","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants. Cell Discov. 8, 136 (2022).","journal-title":"Cell Discov."},{"key":"72647_CR55","doi-asserted-by":"publisher","first-page":"23695","DOI":"10.1073\/pnas.2003932117","volume":"117","author":"W Liu","year":"2020","unstructured":"Liu, W. et al. LncRNA Malat1 inhibition of TDP43 cleavage suppresses IRF3-initiated antiviral innate immunity. Proc. Natl. Acad. Sci. USA 117, 23695\u201323706 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72647_CR56","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41392-021-00477-8","volume":"6","author":"Z Yu","year":"2021","unstructured":"Yu, Z. et al. TRIM41 is required to innate antiviral response by polyubiquitinating BCL10 and recruiting NEMO. Signal Transduct. Target Ther. 6, 90 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"72647_CR57","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.immuni.2020.11.010","volume":"53","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Decreased expression of the host long-noncoding rna-gm facilitates viral escape by inhibiting the kinase activity TBK1 via S-glutathionylation. Immunity 53, 1168\u20131181 (2020).","journal-title":"Immunity"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72647-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72647-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72647-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:05:04Z","timestamp":1783641904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72647-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72647"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72647-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6063"}}